Opioid Therapies and Cytochrome P450 Interactions

被引：48
|
作者：
Gudin, Jeffrey [1 ]
机构：
[1] Englewood Hosp & Med Ctr, Pain Management & Wellness Ctr, Englewood, NJ 07631 USA
来源：
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT | 2012年 / 44卷 / 06期
关键词：
Adverse drug reactions; cytochrome P450; CYP3A4; CYP2D6; drug-drug interactions; inhibitor; inducer; metabolism; prodrug; substrate; opioids; DRUG-DRUG INTERACTIONS; ST-JOHNS-WORT; CAFFEINE METABOLISM; PHARMACOGENETICS; INHIBITION; CYP2D6; PAIN; VARIABILITY; HYDROCODONE; OXYMORPHONE;
D O I：
10.1016/j.jpainsymman.2012.08.013
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
Adverse drug reactions are common and associated with substantial economic and human costs. Particularly among older adult populations, preventable adverse drug reactions are often caused by drug-drug interactions. All analgesics have side effect profiles and many have known drug-drug interactions. Opioids are recognized as a necessary option for managing moderate-to-severe pain, yet many opioid side effects can be enhanced by metabolic interactions within the liver, involving other drugs, diseases, or genetics. J Pain Symptom Manage 2012; 44: S4-S14. (C) 2012 U. S. Cancer Pain Relief Committee. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码：S4 / S14
页数：11
相关论文
共 50 条
  • [21] Cytochrome P450 drug interactions with statin therapy
    Goh, Ivanna Xin Wei
    How, Choon How
    Tavintharan, Subramaniam
    SINGAPORE MEDICAL JOURNAL, 2013, 54 (03) : 131 - 135
  • [22] Cytochrome P450 interactions and clinical implication in rheumatology
    Audrey Cayot
    Davy Laroche
    Anne Disson-Dautriche
    Anaïs Arbault
    Jean-Francis Maillefert
    Paul Ornetti
    Clinical Rheumatology, 2014, 33 : 1231 - 1238
  • [23] Cytochrome P450
    P. H. Roos
    N. Jakubowski
    Analytical and Bioanalytical Chemistry, 2008, 392 : 1015 - 1017
  • [24] Cytochrome P450 enzymes and their role in drug interactions
    Papp-Jámbor, C
    Jaschinski, U
    Forst, H
    ANAESTHESIST, 2002, 51 (01): : 2 - 15
  • [25] Conformational Landscape of Cytochrome P450 Reductase Interactions
    Sellner, Manuel
    Fischer, Andre
    Don, Charleen G.
    Smiesko, Martin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (03) : 1 - 14
  • [26] INTERACTIONS OF ICLAPRIM WITH HUMAN CYTOCHROME P450 ENZYMES
    Hall, Michael
    Matthews, Anne
    Paul, Danny S.
    Foster, John R.
    Holding, Jeremy D.
    Islam, Khalid
    Brandt, Roger D.
    DRUG METABOLISM REVIEWS, 2007, 39 : 210 - 210
  • [27] Cytochrome P450
    Roos, P. H.
    Jakubowski, N.
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2008, 392 (06) : 1015 - 1017
  • [28] Cytochrome P450
    Poulos, TL
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 1995, 5 (06) : 767 - 774
  • [29] Interactions between cytochrome P450 and cytochrome b5
    Schenkman, JB
    Jansson, I
    DRUG METABOLISM REVIEWS, 1999, 31 (02) : 351 - 364
  • [30] Uncovering the Role of Hydrophobic Residues in Cytochrome P450-Cytochrome P450 Reductase Interactions
    Kenaan, Cesar
    Zhang, Haoming
    Shea, Erin V.
    Hollenberg, Paul F.
    BIOCHEMISTRY, 2011, 50 (19) : 3957 - 3967
12345